InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Friday, 08/26/2022 11:28:00 PM

Friday, August 26, 2022 11:28:00 PM

Post# of 14947
Here are 6 Sorrento programs which are advancing nicely.
*SEMDEXA completed PHASE 3 with excellent results.
*ABIVERTINIB completed PHASE 3 with excellent results.
*Anti-PD-L1 enrollment for a multi-regional PHASE 3 has completed.
*Mpro to initiate PHASE 2/ 3 this year. Could include Australia, China, Mexico and US.
*VIREX prototype field testing for regulatory approval Q3/Q4 2022.
*RTX two PHASE 2 studies are currently enrolling.

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRNE News